Point-of-care CD4 testing: Differentiated care for the most vulnerable
Open Access
- 5 February 2022
- journal article
- research article
- Published by International Society of Global Health in Journal of Global Health
- Vol. 12, 04004
Abstract
South Africa, with the highest burden of HIV infection globally, has made huge strides in its HIV/ART programme, but AIDS deaths have not decreased proportionally to ART uptake. Advanced HIV disease (CD4 < 200 cells/mm3) persists, and CD4 count testing is being overlooked since universal test-and-treat was implemented. Point-of-care CD4 testing could address this gap and assure differentiated care to these vulnerable patients with low CD4 counts. A time randomised implementation trial was conducted, enrolling 603 HIV positive non-ART, not pregnant patients at a primary health care clinic in Durban, South Africa. Weeks were randomised to either point-of-care CD4 testing (n = 305 patients) or standard-of-care central laboratory CD4 testing (n = 298 patients) to assess the proportion initiating ART at 3 months. Cox regression, with robust standard errors adjusting for clustering by week, were used to assess the relationship between treatment initiation and arm. Among the 578 (299 point-of-care and 279 standard-of-care) patients eligible for analysis, there was no significant difference in the number of eligible patients initiating ART within 3 months in the point-of-care (73%) and the standard-of-care (68%) groups (P = 0.112). The time-to-treat analysis was not significantly different in patients with CD4 counts of 201-500 cells/mm3 which could have been due to appointment scheduling to cope with the large burden of cases. However, in patients with advanced HIV disease (CD4 < 200cells/mm3) 65% more patients started ART earlier in the point-of-care group (HR 1.65 (95% confidence interval (CI) = 0.99-2.75; P = 0.052) compared to the standard-of-care group. Point-of-care testing decreased time-to-treatment in those with advanced HIV disease. With universal test and treat for HIV, rollout of simple point-of-care CD4 testing would ensure early diagnosis of advanced HIV disease and facilitate differentiated care for these vulnerable patients as per the World Health Organisation 2020 target product profile for point-of-care CD4 testing. ISRCTN14220457.Keywords
This publication has 63 references indexed in Scilit:
- Determinants of loss to follow-up in patients on antiretroviral treatment, South Africa, 2004–2012: a cohort studyBMC Health Services Research, 2015
- Estimation of mortality among HIV-infected people on antiretroviral treatment in east Africa: a sampling based approach in an observational, multisite, cohort studyThe Lancet HIV, 2015
- Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD StatementBMC Medicine, 2015
- Initiation of antiretroviral therapy and viral suppression after home HIV testing and counselling in KwaZulu-Natal, South Africa, and Mbarara district, Uganda: a prospective, observational intervention studyThe Lancet HIV, 2014
- Impact of point‐of‐care CD4 testing on linkage to HIV care: a systematic reviewJournal of the International AIDS Society, 2014
- Mortality, AIDS-Morbidity, and Loss to Follow-up by Current CD4 Cell Count Among HIV-1–Infected Adults Receiving Antiretroviral Therapy in Africa and AsiaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2013
- Rates and Cost of Hospitalization Before and After Initiation of Antiretroviral Therapy in Urban and Rural Settings in South AfricaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2013
- Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort studyThe Lancet, 2011
- Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South AfricaAIDS, 2009
- The frequency of missed test results and associated treatment delays in a highly computerized health systemBMC Family Practice, 2007